341 related articles for article (PubMed ID: 12902473)
1. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors.
Peters B; Bulik S; Tampe R; Van Endert PM; Holzhütter HG
J Immunol; 2003 Aug; 171(4):1741-9. PubMed ID: 12902473
[TBL] [Abstract][Full Text] [Related]
2. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.
Luckey CJ; Marto JA; Partridge M; Hall E; White FM; Lippolis JD; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 2001 Aug; 167(3):1212-21. PubMed ID: 11466336
[TBL] [Abstract][Full Text] [Related]
3. Transporter associated with antigen processing preselection of peptides binding to the MHC: a bioinformatic evaluation.
Doytchinova I; Hemsley S; Flower DR
J Immunol; 2004 Dec; 173(11):6813-9. PubMed ID: 15557175
[TBL] [Abstract][Full Text] [Related]
4. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
[TBL] [Abstract][Full Text] [Related]
5. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
[TBL] [Abstract][Full Text] [Related]
6. Sequential cleavage by metallopeptidases and proteasomes is involved in processing HIV-1 ENV epitope for endogenous MHC class I antigen presentation.
López D; Gil-Torregrosa BC; Bergmann C; Del Val M
J Immunol; 2000 May; 164(10):5070-7. PubMed ID: 10799863
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation.
Choppin J; Cohen W; Bianco A; Briand JP; Connan F; Dalod M; Guillet JG
J Immunol; 2001 May; 166(10):6164-9. PubMed ID: 11342637
[TBL] [Abstract][Full Text] [Related]
8. Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
Beekman NJ; van Veelen PA; van Hall T; Neisig A; Sijts A; Camps M; Kloetzel PM; Neefjes JJ; Melief CJ; Ossendorp F
J Immunol; 2000 Feb; 164(4):1898-905. PubMed ID: 10657639
[TBL] [Abstract][Full Text] [Related]
9. Integrated modeling of the major events in the MHC class I antigen processing pathway.
Dönnes P; Kohlbacher O
Protein Sci; 2005 Aug; 14(8):2132-40. PubMed ID: 15987883
[TBL] [Abstract][Full Text] [Related]
10. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding.
Tenzer S; Peters B; Bulik S; Schoor O; Lemmel C; Schatz MM; Kloetzel PM; Rammensee HG; Schild H; Holzhütter HG
Cell Mol Life Sci; 2005 May; 62(9):1025-37. PubMed ID: 15868101
[TBL] [Abstract][Full Text] [Related]
11. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules.
Daniel S; Brusic V; Caillat-Zucman S; Petrovsky N; Harrison L; Riganelli D; Sinigaglia F; Gallazzi F; Hammer J; van Endert PM
J Immunol; 1998 Jul; 161(2):617-24. PubMed ID: 9670935
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte epitopes of HIV-1 Nef: Generation of multiple definitive major histocompatibility complex class I ligands by proteasomes.
Lucchiari-Hartz M; van Endert PM; Lauvau G; Maier R; Meyerhans A; Mann D; Eichmann K; Niedermann G
J Exp Med; 2000 Jan; 191(2):239-52. PubMed ID: 10637269
[TBL] [Abstract][Full Text] [Related]
13. Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes.
Lemberg MK; Bland FA; Weihofen A; Braud VM; Martoglio B
J Immunol; 2001 Dec; 167(11):6441-6. PubMed ID: 11714810
[TBL] [Abstract][Full Text] [Related]
14. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.
Larsen MV; Lundegaard C; Lamberth K; Buus S; Brunak S; Lund O; Nielsen M
Eur J Immunol; 2005 Aug; 35(8):2295-303. PubMed ID: 15997466
[TBL] [Abstract][Full Text] [Related]
15. The murine cytomegalovirus pp89 immunodominant H-2Ld epitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide.
Knuehl C; Spee P; Ruppert T; Kuckelkorn U; Henklein P; Neefjes J; Kloetzel PM
J Immunol; 2001 Aug; 167(3):1515-21. PubMed ID: 11466372
[TBL] [Abstract][Full Text] [Related]
16. Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport.
Fruci D; Lauvau G; Saveanu L; Amicosante M; Butler RH; Polack A; Ginhoux F; Lemonnier F; Firat H; van Endert PM
J Immunol; 2003 Mar; 170(6):2977-84. PubMed ID: 12626550
[TBL] [Abstract][Full Text] [Related]
17. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
Bai A; Forman J
J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL.
Andersen MH; Bonfill JE; Neisig A; Arsequell G; Sondergaard I; Valencia G; Neefjes J; Zeuthen J; Elliott T; Haurum JS
J Immunol; 1999 Oct; 163(7):3812-8. PubMed ID: 10490979
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.
Schwarz K; van Den Broek M; Kostka S; Kraft R; Soza A; Schmidtke G; Kloetzel PM; Groettrup M
J Immunol; 2000 Jul; 165(2):768-78. PubMed ID: 10878350
[TBL] [Abstract][Full Text] [Related]
20. A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway.
Herberts CA; Stittelaar KJ; van der Heeft E; van Gaans-van den Brink J; Poelen MCM; Roholl PJM; van Alphen LJW; Melief CJM; de Jong APJM; van Els CACM
J Gen Virol; 2001 Sep; 82(Pt 9):2131-2142. PubMed ID: 11514722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
